Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for receivables	$ 7,097	$ 7,967
Accumulated depreciation	157,278	143,831
Accumulated amortization	$ 10,334	$ 8,738
Common stock, authorized (in shares)	300,000,000	1,000
Common stock, stated value (in dollars per share)	$ 0.01	$ 1
Common stock, issued (in shares)	50,980,924	1,000
Common stock, outstanding (in shares)	50,980,924	1,000